biote Corp.
BTMD
$3.47
$0.041.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.38% | 4.84% | 3.70% | 8.49% | 12.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.38% | 4.84% | 3.70% | 8.49% | 12.37% |
| Cost of Revenue | 0.44% | -2.47% | -2.81% | 2.12% | 6.05% |
| Gross Profit | 9.08% | 8.32% | 6.81% | 11.57% | 15.49% |
| SG&A Expenses | 13.22% | 13.43% | 12.57% | -42.24% | -39.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.20% | 6.85% | 6.17% | -30.43% | -26.84% |
| Operating Income | -0.67% | -2.25% | -4.99% | 205.38% | 203.84% |
| Income Before Tax | 926.02% | 205.44% | 201.22% | 160.88% | -107.18% |
| Income Tax Expenses | -63.83% | -50.03% | 62.24% | 375.68% | 591.24% |
| Earnings from Continuing Operations | 101.64% | 516.63% | 173.63% | 143.51% | -311.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -49.17% | -101.25% | -206.41% | -121.97% | 366.94% |
| Net Income | -4.79% | 357.08% | 138.95% | 203.56% | 442.21% |
| EBIT | -0.67% | -2.25% | -4.99% | 205.38% | 203.84% |
| EBITDA | 1.19% | -1.85% | -4.69% | 211.12% | 209.61% |
| EPS Basic | 178.82% | 217.03% | 130.98% | 130.88% | -101.70% |
| Normalized Basic EPS | -42.20% | 10.77% | -85.07% | 123.32% | 135.90% |
| EPS Diluted | 132.78% | 130.15% | 103.65% | 107.31% | -103.02% |
| Normalized Diluted EPS | -44.27% | -46.81% | -88.57% | 135.11% | 143.63% |
| Average Basic Shares Outstanding | 26.72% | 71.63% | 141.78% | 188.52% | 226.18% |
| Average Diluted Shares Outstanding | 3.44% | 27.50% | 54.89% | 63.60% | 62.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.44% | 1.23% | 2.50% | 1.41% | 1.20% |